These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33997885)

  • 21. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas.
    Deutschbein T; Unger N; Hinrichs J; Walz MK; Mann K; Petersenn S
    Eur J Endocrinol; 2009 Nov; 161(5):747-53. PubMed ID: 19726566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
    J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry.
    Sasaki Y; Katabami T; Asai S; Fukuda H; Tanaka Y
    Endocr J; 2017 Sep; 64(9):833-842. PubMed ID: 28637948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
    Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas.
    Ueland GÅ; Grinde T; Methlie P; Kelp O; Løvås K; Husebye ES
    Endocr Connect; 2020 Oct; 9(10):963-970. PubMed ID: 33032259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
    Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
    Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P; Bertolini M; Losa M; Cavagnini F
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
    Araujo-Castro M; García Cano AM; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives.
    Carton T; Mathieu E; Wolff F; Bouziotis J; Corvilain B; Driessens N
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00255. PubMed ID: 34277979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
    Patrova J; Kjellman M; Wahrenberg H; Falhammar H
    Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.
    Ceccato F; Marcelli G; Martino M; Concettoni C; Brugia M; Trementino L; Michetti G; Arnaldi G
    J Endocrinol Invest; 2019 Mar; 42(3):327-335. PubMed ID: 29987756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum cortisol assay performance following the 1 mg overnight dexamethasone suppression test.
    Atkins JS; Hawley JM; Owen LJ; Clayton J; Scargill J; Keevil BG
    Ann Clin Biochem; 2023 Nov; 60(6):386-395. PubMed ID: 37208338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing's syndrome.
    Oki Y; Hashimoto K; Hirata Y; Iwasaki Y; Nigawara T; Doi M; Sakihara S; Kageyama K; Suda T
    Endocr J; 2009; 56(7):897-904. PubMed ID: 19706991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroidogenesis in patients with adrenal incidentalomas: Extended steroid profile measured by liquid chromatography-mass spectrometry after ACTH stimulation and dexamethasone suppression.
    Huayllas MKP; Smith LM; Gallagher JC; Netzel BC; Singh RJ; Kater CE
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):29-40. PubMed ID: 33598999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.